ESSILORLUXOTTICA UNSPON ADR EAC (ESLOY) Financials
ESLOY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 66.9 billion | 23.9 billion |
2023-09-30 | 64.1 billion | 22.9 billion |
2023-06-30 | 65.5 billion | 23.8 billion |
2023-03-31 | 65.6 billion | 23.8 billion |
ESLOY Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 2.1 billion | 77.9 million |
2023-09-30 | 1.0 billion | 74.6 million |
2023-06-30 | 1.5 billion | 42.9 million |
2023-03-31 | 776.6 million | 43.1 million |
ESLOY Net Income
Date | Net Income |
---|---|
2023-12-31 | 1.0 billion |
2023-09-30 | 491.2 million |
2023-06-30 | 1.5 billion |
2023-03-31 | 741.8 million |
ESLOY Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 2.8 billion | - | 3.6 billion |
2023-09-30 | 2.7 billion | - | - |
2023-06-30 | 1.8 billion | - | 3.5 billion |
2023-03-31 | 1.8 billion | - | - |
ESLOY Shares Outstanding
ESLOY Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 862.3 million | 323.9 million | 579.8 million | 2.7 billion |
2023-09-30 | 412.9 million | 227.6 million | 555.3 million | 2.6 billion |
2023-06-30 | 816.6 million | 326.2 million | 603.5 million | 2.6 billion |
2023-03-31 | 409.3 million | 237.6 million | 605.0 million | 2.7 billion |
ESLOY Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 13.9 billion | 5.2 billion |
2023-09-30 | 6.6 billion | 2.5 billion |
2023-06-30 | 14.0 billion | 5.0 billion |
2023-03-31 | 7.0 billion | 2.6 billion |
ESLOY
Price: $106.93
Dividend Yield: 1.59%
Forward Dividend Yield: 1.97%
Payout Ratio: 63.02%
Dividend Per Share: 2.11 USD
Earnings Per Share: 2.76 USD
P/E Ratio: 35.84
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 6244
Market Capitalization: 97.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 19
DGR3: 15.75%